Click to view your profile
Click to search for condition or expert
Click to open main menu
Bladder Cancer Latest Advances
Find the Latest Research About Bladder Cancer
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/06/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 617 publications
See more filters
A case of undifferentiated carcinoma of the bladder treated by combination therapy of surgery, local radiation, and immune checkpoint inhibitors.
Condition:
Undifferentiated Carcinoma of Bladder
Journal:
Nagoya journal of medical science
Treatment Used:
Surgery, Local Radiation, and Immune Checkpoint Inhibitors
Number of Patients:
1
Published:
December 22, 2022
VIEW PUBLICATION
A rare case of bladder cancer that metastasized to brain, heart, and lung lymph nodes benefited from immunotherapy.
Condition:
Bladder Cancer with Multiple Metastases
Journal:
World journal of surgical oncology
Treatment Used:
Tislelizumab Immunotherapy
Number of Patients:
1
Published:
December 18, 2022
VIEW PUBLICATION
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study.
Condition:
Norwegian Patients with Muscle-Invasive Bladder Cancer (MIBC)
Journal:
BMC cancer
Treatment Used:
Neoadjuvant Chemotherapy (NAC)
Number of Patients:
575
Published:
December 12, 2022
VIEW PUBLICATION
Refractory paraneoplastic hypercalcaemia responding to cinacalcet.
Condition:
Refractory Paraneoplastic Hypercalcemia
Journal:
BMJ case reports
Treatment Used:
Cinacalcet
Number of Patients:
1
Published:
November 15, 2022
VIEW PUBLICATION
Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab.
Condition:
Small Cell Bladder Carcinoma (SCBC)
Journal:
BMC urology
Treatment Used:
Carboplatin, Etoposide, and Atezolizumab
Number of Patients:
1
Published:
November 06, 2022
VIEW PUBLICATION
Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report.
Condition:
Advanced Recurrent Basal Cell Carcinoma and Urothelial Carcinoma of Bladder
Journal:
Journal of medical case reports
Treatment Used:
Atezolizumab
Number of Patients:
1
Published:
November 01, 2022
VIEW PUBLICATION
Disitamab vedotin, a novel HER2-directed antibody-drug conjugate in gastric cancer and other solid tumors.
Condition:
Gastric Cancer and Other Solid Tumors
Journal:
Drugs of today (Barcelona, Spain : 1998)
Treatment Used:
Disitamab Vedotin
Number of Patients:
0
Published:
October 28, 2022
VIEW PUBLICATION
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.
Condition:
Muscle-Invasive Bladder Cancer
Journal:
The Journal of urology
Treatment Used:
Repeat Transurethral Resection Prior to Radical Cystectomy
Number of Patients:
548
Published:
October 17, 2022
VIEW PUBLICATION
Re-Administration of Pembrolizumab for Urothelial Carcinoma after immune-Related Myasthenia Gravis : A Case Report.
Condition:
Urothelial Carcinoma after Immune-Related Myasthenia Gravis
Journal:
Hinyokika kiyo. Acta urologica Japonica
Treatment Used:
Pembrolizumab
Number of Patients:
1
Published:
October 06, 2022
VIEW PUBLICATION
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
Condition:
Muscle-Invasive Bladder Cancer (MIBC)
Journal:
World journal of urology
Treatment Used:
Neoadjuvant and Induction Gemcitabine-Carboplatin vs. Gemcitabine-Cisplatin Followed by Radical Cystectomy (RC)
Number of Patients:
1865
Published:
September 28, 2022
VIEW PUBLICATION
Simple cholecystectomy is an adequate treatment for grade I T1bN0M0 gallbladder carcinoma: Evidence from 528 patients.
Condition:
Grade I T1bN0M0 Gallbladder Carcinoma (GBC)
Journal:
World journal of gastroenterology
Treatment Used:
Cholecystectomy
Number of Patients:
528
Published:
September 26, 2022
VIEW PUBLICATION
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy.
Condition:
Advanced Upper Tract Urothelial Carcinoma (UTUC)
Journal:
Oncoimmunology
Treatment Used:
PD-1 Inhibitor
Number of Patients:
123
Published:
September 23, 2022
VIEW PUBLICATION
Showing 1-12 of 617
Next
Last Updated: 01/06/2023